Shaun Rodriguez
Directeur/Bestuurslid bij Multiply Labs, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Federico Parietti | M | - |
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | - |
Patrick Arensdorf | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
Alice Melocchi | M | - |
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | - |
Babak Alipanahi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
Hani Goodarzi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
Emilia Bulaevsky Zychlinsky | M | 68 |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | 1 jaar |
Mike Pellini | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
Michael Doherty | M | - |
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | - |
Arcediano jason | M | - |
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | 2 jaar |
Marae Hartwell | F | - |
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | - |
Krishnan Viswanadhan | M | - |
Multiply Labs, Inc.
Multiply Labs, Inc. Pharmaceuticals: MajorHealth Technology Multiply Labs, Inc. provides individuals to customize their intake of supplements to optimize their day. It offers vitamins, omega 3, iron, folic acid and caffeine medicines. The company was founded by Alice Melocchi, Tiffany Kuo, Fred Parietti and Joe Wilson and is headquartered in San Francisco, CA. | - |
Seema Bhan | F | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 12 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Shaun Rodriguez
- Persoonlijk netwerk